Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

106.94USD
30 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$106.94
Open
--
Day's High
--
Day's Low
--
Volume
500
Avg. Vol
4,799,684
52-wk High
$107.35
52-wk Low
$66.85

Search Stocks
Drake Rodman L Options Exercised: 0
Trade Date: Thursday, 30 Jan 2014 Price: 38.43
Title: Director Shares Held: 22,597
Type Traded: Direct Net Change in Shares This Filing: 2,000

Institutional Holders

% Shares Owned: 82.23%
# of Holders: 1,301
Total Shares Held: 657,456,234
3 Mo. Net Change: -2,322,886
# New Positions: 32
# Closed Positions: 23
# Increased Positions: 167
# Reduced Positions: 165
# Net Buyers: 2

Officers & Directors

Name Age Since Current Position

Robert Hugin

59 2011 Chairman of the Board, President, Chief Executive Officer

Mark Alles

55 2014 President, Chief Operating Officer

Peter Kellogg

58 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

52 2014 President - Hematology & Oncology

Tuomo Patsi

President - Europe, Middle East and Africa (EMEA)

Scott Smith

2014 President - Inflammation & Immunology

Perry Karsen

58 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

64 2012 Executive Vice President, General Counsel, Corporate Secretary

Thomas Daniel

60 2012 Executive Vice President, President - Research and Early Development

Michael Casey

68 2007 Lead Independent Director

Richard Barker

65 2012 Independent Director

Carrie Cox

57 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

67 1998 Independent Director

James Loughlin

71 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks